- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Spago Nanomedical AB (publ) receives observation status | 312 | GlobeNewswire | Yesterday, October 22, 2026, Spago Nanomedical AB (publ) (the "Company") issued a press release stating that the Company's board of directors had resolved to apply for the removal of the Company's... ► Artikel lesen | |
| Do | The Board of Directors of Spago Nanomedical Has Resolved, Subject to the Approval of the General Meeting, to Apply for Delisting From the NASDAQ First North Growth Market | 383 | ACCESS Newswire | LUND, SE / ACCESS Newswire / October 22, 2026 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) - The Board of Directors of Spago Nanomedical AB (publ), company registration number 556574-5048 ("Spago Nanomedical"... ► Artikel lesen | |
| Do | Notice of Extraordinary General Meeting in Spago Nanomedical AB | 345 | ACCESS Newswire | LUND, SE / ACCESS Newswire / October 22, 2026 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) - The shareholders of Spago Nanomedical AB (publ), corporate registration number 556574-5048 ("Spago Nanomedical"... ► Artikel lesen | |
| Do | Bulletin from the Extraordinary General Meeting of Spago Nanomedical AB | 233 | ACCESS Newswire | LUND, SE / ACCESS Newswire / October 22, 2026 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) - The Extraordinary General Meeting of Spago Nanomedical AB (publ) was held today, October 22, 2026, at which... ► Artikel lesen | |
| Do | Spago Nanomedical AB: Bulletin from the Extraordinary General Meeting of Spago Nanomedical AB | 118 | GlobeNewswire (Europe) | The Extraordinary General Meeting of Spago Nanomedical AB (publ) was held today, October 22, 2026, at which the following resolutions were passed.
The Extraordinary General Meeting resolved to implement... ► Artikel lesen | |
| 29.09. | Spago Nanomedical to Participate in Several International Industry Conferences During Autumn 2026 | 336 | ACCESS Newswire | LUND, SE / ACCESS Newswire / September 29, 2026 / Spago Nanomedical AB (publ) (STO:SPAGO.ST)(FRA:7UX.F) today announces that the company will participate in five international conferences during autumn... ► Artikel lesen | |
| 21.09. | Notice Of Extraordinary General Meeting in Spago Nanomedical AB | 334 | ACCESS Newswire | LUND, SE / ACCESS Newswire / September 21, 2026 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) - The shareholders of Spago Nanomedical AB (publ), corporate registration number 556574-5048, are hereby... ► Artikel lesen | |
| SPAGO NANOMEDICAL Aktie jetzt für 0€ handeln | |||||
| 20.08. | Spago Nanomedical AB Q2 Sales Decline | 2 | RTTNews | ||
| 20.08. | Spago Nanomedical Interim Report January-June 2026 | 513 | ACCESS Newswire | LUND, SE / ACCESS Newswire / August 20, 2026 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F)APRIL - JUNE IN BRIEFNet sales for the quarter amounted to KSEK 0 (KSEK 81)The loss for the quarter amounted... ► Artikel lesen | |
| 18.06. | Spago Nanomedical AB: Spago Nanomedical announces outcome of rights issue | 294 | GlobeNewswire (Europe) | NOT INTENDED FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, SWITZERLAND, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| 10.06. | Bulletin from the 2026 Annual General Meeting of Spago Nanomedical AB | 381 | ACCESS Newswire | LUND, SE / ACCESS Newswire / June 10, 2026 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) - The Annual General Meeting (AGM) of Spago Nanomedical AB (publ) was held today, June 10, 2026, at which the... ► Artikel lesen | |
| 03.06. | The Subscription Period in Spago Nanomedical's Rights Issue Begins Today | 505 | ACCESS Newswire | NOT INTENDED FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, SWITZERLAND, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| 03.06. | Spago Nanomedical AB: The subscription period in Spago Nanomedical's rights issue begins today | 228 | GlobeNewswire (Europe) | NOT INTENDED FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, SWITZERLAND, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| 02.06. | Listing of subscription rights and paid subscription shares of Spago Nanomedical AB | 329 | GlobeNewswire | With effect from June 03, 2026, the subscription rights in Spago Nanomedical AB will be traded on First North Growth Market. Trading will continue up until and including June 12, 2026.
... ► Artikel lesen | |
| 02.06. | Spago Nanomedical AB: Spago Nanomedical publishes information document in connection with forthcoming rights issue | 206 | GlobeNewswire (Europe) | NOT INTENDED FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, SWITZERLAND, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| 29.05. | XFRA CAPITAL ADJUSTMENT INFORMATION - 29.05.2026 | 572 | Xetra Newsboard | Das Instrument TAH JP3634600005 TOYOTA INDS EQUITY wird cum Kapitalmassnahme gehandelt am 29.05.2026 und ex Kapitalmassnahme am 01.06.2026 The instrument TAH JP3634600005 TOYOTA INDS EQUITY is traded... ► Artikel lesen | |
| 22.05. | Spago Nanomedical Resolves on a Rights Issue of Approximately SEK 16 Million | 477 | ACCESS Newswire | NOT INTENDED FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, SWITZERLAND, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| 19.05. | Spago Nanomedical Publishes the Annual Report for 2025 | 436 | ACCESS Newswire | LUND, SE / ACCESS Newswire / May 19, 2026 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F)Spago Nanomedical's annual report for 2025 is from today available at the company's website, https://spagonanomedical.se/investor-relations/financial-reportsFor... ► Artikel lesen | |
| 18.05. | Spago Nanomedical Presents Tumorad Clinical Data at the International ANZSNM 2026 Conference | 372 | ACCESS Newswire | LUND, SE / ACCESS Newswire / May 18, 2026 / Spago Nanomedical AB (publ)(STO:SPAGO.ST)(FRA:7UX.F) today announces that case findings from its ongoing Phase I/IIa clinical study Tumorad-01 have been presented... ► Artikel lesen | |
| 11.05. | Notice To Annual General Meeting of Spago Nanomedical AB | 339 | ACCESS Newswire | LUND, SE / ACCESS Newswire / May 11, 2026 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F)This English version of the notice to the Annual General Meeting is for convenience only. The Swedish version prevails... ► Artikel lesen |
1 2 Weiter >>
33 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| QIAGEN | 45,050 | +0,26 % | EQS-WpÜG: Übernahmeangebot / Zielgesellschaft: Qiagen N.V.; Bieter: Crown NL Bidco B.V. | EQS-WpÜG: Crown NL Bidco B.V. / Übernahmeangebot
Übernahmeangebot / Zielgesellschaft: Qiagen N.V.; Bieter: Crown NL Bidco B.V.
21.10.2026 / 23:30 CET/CEST
Veröffentlichung einer... ► Artikel lesen | |
| TANGO THERAPEUTICS | 23,360 | +0,09 % | Wedbush raises Tango Therapeutics stock price target on trial data | ||
| COGENT BIOSCIENCES | 31,210 | 0,00 % | If You Invested $1000 In Cogent Biosciences Stock 5 Years Ago, You Would Have This Much Today | ||
| SUMMIT THERAPEUTICS | 15,470 | 0,00 % | Akeso, Inc.: Akeso Announces Summit Therapeutics and ECOG-ACRIN Cancer Research Group Enter into Phase II/III Clinical Trial Collaboration to Evaluate Ivonescimab in First-Line Biliary Tract Cancer | Becomes the 7th International Registrational Clinical Trial for Ivonescimab
Clinical Trial Site Activations in the United States Expected to Begin Q4 2026
HONG... ► Artikel lesen | |
| MODERNA | 178,42 | -0,19 % | Sell the News: Warum starke Studiendaten den Moderna-Kurs crashen lassen | Die Moderna-Aktie stürzt trotz starker Studiendaten zum Krebsimpfstoff mit Merck um mehr als 25 Prozent ab. Analysten sehen eine klassische Sell-the-News-Reaktion nach monatelanger Kursrallye. Die Moderna-Aktie... ► Artikel lesen | |
| KINIKSA PHARMACEUTICALS | 76,73 | 0,00 % | AstraZeneca, Cardiol Therapeutics, Kiniksa - Neue Hoffnung für Herzpatienten | Herz-Kreislauf-Erkrankungen gehören weltweit zu den größten medizinischen Herausforderungen. Während etablierte Pharmakonzerne Milliarden in neue Wirkstoffe und Künstliche Intelligenz investieren, entwickeln... ► Artikel lesen | |
| AMYLYX PHARMACEUTICALS | 27,200 | 0,00 % | Biotech Stocks At 52-Week Highs - Amylyx Pharmaceuticals +63% With Phase 3 Data, Vogenx +25%, Orchestra BioMed +19%, AtriCure, Charles River Laboratories | WASHINGTON (dpa-AFX) - The following biotech stocks reached a 52-week high on August 18, 2026, primarily driven by positive quarterly reports.Amylyx Pharmaceuticals Inc. (AMLX)Amylyx Pharmaceuticals... ► Artikel lesen | |
| LYCIA THERAPEUTICS | 29,560 | -1,47 % | Lycia Therapeutics Prices Upsized $317.5 Mln IPO At $18/Share | WASHINGTON (dpa-AFX) - Lycia Therapeutics Inc. (LYCA) a clinical-stage biotechnology company developing treatments for autoimmune, inflammatory, and allergic diseases, said Thursday it priced... ► Artikel lesen | |
| ENLIVEN THERAPEUTICS | 41,520 | 0,00 % | H.C. Wainwright hebt Kursziel für Enliven Therapeutics auf 73 $ an | ||
| PRAXIS PRECISION MEDICINES | 252,88 | -0,03 % | Praxis Precision Medicines, Inc.: Praxis Precision Medicines Announces Extension Period for Relutrigine for Treatment of SCN2A and SCN8A Developmental and Epileptic Encephalopathies | FDA sets updated PDUFA date of December 27, 2026 BOSTON, June 29, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS)... ► Artikel lesen | |
| ARRIVENT BIOPHARMA | 21,010 | +0,05 % | ArriVent to present phase 1 data for ARR-217 at ESMO | ||
| BOLT BIOTHERAPEUTICS | 6,250 | -0,32 % | Bolt Biotherapeutics, Inc. - 8-K, Current Report | ||
| TRAVERE THERAPEUTICS | 50,05 | 0,00 % | Biotech Stocks At 52-Week Highs - Bioventus, Travere Therapeutics, Odyssey Therapeutics, Charles River Laboratories Climb With Q2 Results, Aclaris Therapeutics | WASHINGTON (dpa-AFX) - The following biotech stocks reached a 52-week high on August 5, 2026, primarily driven by positive quarterly reports.Bioventus Inc. (BVS)Bioventus is a medical device... ► Artikel lesen | |
| HARMONY BIOSCIENCES | 36,100 | -0,08 % | Harmony Biosciences: Mizuho bekräftigt Einstufung nach Verhandlungen im Patentrechtsstreit | ||
| RECURSION PHARMACEUTICALS | 3,695 | -0,14 % | Cathie Wood's weekly recap: adds to CoreWeave, Meta, Recursion; cuts Personalis, Toast |
Das Unternehmen SPAGO NANOMEDICAL AB kann der Branche Biotechnologie zugeordnet werden. Der aktuelle Kurs liegt bei 0,003 Euro und damit -58,54 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SPAGO NANOMEDICAL AB finden Sie auf Wallstreet Online.